Supplementary Figure S9 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency
Key points are not available for this paper at this time.
Abstract
Figure S9 shows mouse body weight changes in a TNBC PDX model following treatment with LP-184, Olaparib or the combination
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
Supplementary Figure S9 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency | Synapse